Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
Key Statistics for Lung Carcinoid Tumor
About 1% to 2% of all lung cancers are carcinoids. This means there are about 2,000 to 4,500 newly diagnosed lung carcinoid tumors in the United States each year.
Carcinoid tumors actually develop more often in the digestive tract than in the lungs. Only about 2 out of 10 carcinoid tumors start in the lungs.
Lung carcinoids tend to be diagnosed in people who are slightly younger than the typical age of people with other types of lung cancer. The average age of people when they are diagnosed is around 45 years for typical carcinoids and 55 years for atypical carcinoids.
Information on survival rates for lung carcinoids can be found in Survival Rates for Lung Carcinoid Tumors.
Visit the American Cancer Society’s Cancer Statistics Center for more key statistics.
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
American Cancer Society. Cancer Facts & Figures 2022. Atlanta: American Cancer Society; 2022.
Hilal T. Current understanding and approach to well differentiated lung neuroendocrine tumors: an update on classification and management. Therapeutic Advances in Medical Oncology. 2017;9(3):189-199. doi:10.1177/1758834016678149.
Melosky B. Low Grade Neuroendocrine Tumors of the Lung. Frontiers in Oncology. 2017;7:119. doi:10.3389/fonc.2017.00119.
Last Revised: January 12, 2022
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.